L'OREAL (OR.PA) Stock Fundamental Analysis

EPA:OR • FR0000120321

397.4 EUR
-0.05 (-0.01%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall OR gets a fundamental rating of 6 out of 10. We evaluated OR against 16 industry peers in the Personal Care Products industry. OR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, OR is valued expensive at the moment. These ratings could make OR a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year OR was profitable.
  • In the past year OR had a positive cash flow from operations.
  • In the past 5 years OR has always been profitable.
  • OR had a positive operating cash flow in each of the past 5 years.
OR.PA Yearly Net Income VS EBIT VS OCF VS FCFOR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

1.2 Ratios

  • With an excellent Return On Assets value of 11.21%, OR belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
  • OR has a better Return On Equity (19.63%) than 81.25% of its industry peers.
  • OR's Return On Invested Capital of 16.86% is amongst the best of the industry. OR outperforms 81.25% of its industry peers.
Industry RankSector Rank
ROA 11.21%
ROE 19.63%
ROIC 16.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OR.PA Yearly ROA, ROE, ROICOR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 13.96%, OR belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
  • In the last couple of years the Profit Margin of OR has grown nicely.
  • OR has a Operating Margin of 20.41%. This is amongst the best in the industry. OR outperforms 87.50% of its industry peers.
  • In the last couple of years the Operating Margin of OR has remained more or less at the same level.
  • OR has a Gross Margin of 74.11%. This is in the better half of the industry: OR outperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of OR has remained more or less at the same level.
Industry RankSector Rank
OM 20.41%
PM (TTM) 13.96%
GM 74.11%
OM growth 3Y-1.18%
OM growth 5Y0.46%
PM growth 3Y-2.3%
PM growth 5Y1.79%
GM growth 3Y0.9%
GM growth 5Y0.33%
OR.PA Yearly Profit, Operating, Gross MarginsOR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • OR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for OR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OR.PA Yearly Shares OutstandingOR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
OR.PA Yearly Total Debt VS Total AssetsOR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • An Altman-Z score of 7.41 indicates that OR is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of OR (7.41) is better than 93.75% of its industry peers.
  • The Debt to FCF ratio of OR is 1.19, which is an excellent value as it means it would take OR, only 1.19 years of fcf income to pay off all of its debts.
  • OR has a better Debt to FCF ratio (1.19) than 87.50% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that OR is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.20, OR belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.19
Altman-Z 7.41
ROIC/WACC2.09
WACC8.08%
OR.PA Yearly LT Debt VS Equity VS FCFOR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that OR should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.19, OR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • OR has a Quick Ratio of 1.19. This is a bad value and indicates that OR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of OR (0.90) is comparable to the rest of the industry.
  • The current and quick ratio evaluation for OR is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.9
OR.PA Yearly Current Assets VS Current LiabilitesOR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • OR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.39%.
  • Measured over the past years, OR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.73% on average per year.
  • The Revenue has been growing slightly by 1.30% in the past year.
  • The Revenue has been growing by 9.49% on average over the past years. This is quite good.
EPS 1Y (TTM)0.39%
EPS 3Y4.12%
EPS 5Y11.73%
EPS Q2Q%-0.7%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y4.81%
Revenue growth 5Y9.49%
Sales Q2Q%1%

3.2 Future

  • OR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.57% yearly.
  • OR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.15% yearly.
EPS Next Y10.57%
EPS Next 2Y8.94%
EPS Next 3Y9.38%
EPS Next 5Y9.57%
Revenue Next Year4.35%
Revenue Next 2Y4.87%
Revenue Next 3Y5.18%
Revenue Next 5Y6.15%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OR.PA Yearly Revenue VS EstimatesOR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
OR.PA Yearly EPS VS EstimatesOR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 31.27, OR can be considered very expensive at the moment.
  • 68.75% of the companies in the same industry are cheaper than OR, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of OR to the average of the S&P500 Index (27.10), we can say OR is valued inline with the index average.
  • OR is valuated quite expensively with a Price/Forward Earnings ratio of 28.28.
  • 75.00% of the companies in the same industry are cheaper than OR, based on the Price/Forward Earnings ratio.
  • OR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 31.27
Fwd PE 28.28
OR.PA Price Earnings VS Forward Price EarningsOR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 75.00% of the companies in the same industry are cheaper than OR, based on the Enterprise Value to EBITDA ratio.
  • OR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.67
EV/EBITDA 19.84
OR.PA Per share dataOR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • OR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.96
PEG (5Y)2.67
EPS Next 2Y8.94%
EPS Next 3Y9.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

L'OREAL

EPA:OR (2/27/2026, 7:00:00 PM)

397.4

-0.05 (-0.01%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)04-15
Inst Owners15.95%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap212.12B
Revenue(TTM)44.05B
Net Income(TTM)6.12B
Analysts71.11
Price Target409.57 (3.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend6.76
Dividend Growth(5Y)11.22%
DP62.89%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.75%
PT rev (3m)2.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 31.27
Fwd PE 28.28
P/S 4.84
P/FCF 28.67
P/OCF 23.5
P/B 6.8
P/tB 15.52
EV/EBITDA 19.84
EPS(TTM)12.71
EY3.2%
EPS(NY)14.05
Fwd EY3.54%
FCF(TTM)13.86
FCFY3.49%
OCF(TTM)16.91
OCFY4.25%
SpS82.13
BVpS58.41
TBVpS25.6
PEG (NY)2.96
PEG (5Y)2.67
Graham Number129.24
Profitability
Industry RankSector Rank
ROA 11.21%
ROE 19.63%
ROCE 22.82%
ROIC 16.86%
ROICexc 19.21%
ROICexgc 38.99%
OM 20.41%
PM (TTM) 13.96%
GM 74.11%
FCFM 16.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.18%
OM growth 5Y0.46%
PM growth 3Y-2.3%
PM growth 5Y1.79%
GM growth 3Y0.9%
GM growth 5Y0.33%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.19
Debt/EBITDA 0.58
Cap/Depr 83.65%
Cap/Sales 3.71%
Interest Coverage 23.8
Cash Conversion 82.87%
Profit Quality 120.87%
Current Ratio 1.19
Quick Ratio 0.9
Altman-Z 7.41
F-Score7
WACC8.08%
ROIC/WACC2.09
Cap/Depr(3y)85.86%
Cap/Depr(5y)81.08%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.53%
Profit Quality(3y)106.49%
Profit Quality(5y)105.78%
High Growth Momentum
Growth
EPS 1Y (TTM)0.39%
EPS 3Y4.12%
EPS 5Y11.73%
EPS Q2Q%-0.7%
EPS Next Y10.57%
EPS Next 2Y8.94%
EPS Next 3Y9.38%
EPS Next 5Y9.57%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y4.81%
Revenue growth 5Y9.49%
Sales Q2Q%1%
Revenue Next Year4.35%
Revenue Next 2Y4.87%
Revenue Next 3Y5.18%
Revenue Next 5Y6.15%
EBIT growth 1Y8.41%
EBIT growth 3Y3.58%
EBIT growth 5Y9.99%
EBIT Next Year25.9%
EBIT Next 3Y13%
EBIT Next 5Y12.62%
FCF growth 1Y23.2%
FCF growth 3Y13.22%
FCF growth 5Y5.49%
OCF growth 1Y19.52%
OCF growth 3Y11.3%
OCF growth 5Y6.05%

L'OREAL / OR.PA FAQ

What is the ChartMill fundamental rating of L'OREAL (OR.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to OR.PA.


What is the valuation status of L'OREAL (OR.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to L'OREAL (OR.PA). This can be considered as Overvalued.


How profitable is L'OREAL (OR.PA) stock?

L'OREAL (OR.PA) has a profitability rating of 8 / 10.


Can you provide the financial health for OR stock?

The financial health rating of L'OREAL (OR.PA) is 7 / 10.


What is the expected EPS growth for L'OREAL (OR.PA) stock?

The Earnings per Share (EPS) of L'OREAL (OR.PA) is expected to grow by 10.57% in the next year.